COMPASS PATHWAYS

compass-pathways-logo

Compass Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. It is conducting a large-scale psilocybin therapy clinical trial, in 20 sites across nine countries in Europe and North America. It was founded in 2016 and is based in Altrincham, Cheshire.

#SimilarOrganizations #People #Financial #Event #Website #More

COMPASS PATHWAYS

Social Links:

Industry:
Biotechnology Health Care Life Science Personal Health Wellness

Founded:
2016-06-13

Address:
Altrincham, Cheshire, United Kingdom

Country:
United Kingdom

Website Url:
http://www.compasspathways.com

Total Employee:
11+

Status:
Active

Total Funding:
116.21 M USD

Technology used in webpage:
Google Font API Amazon IPv6 COVID-19 Apple Mobile Web App Capable Amazon Virginia Region Amazon S3 CDN Amazon CloudFront Java EE New Relic


Similar Organizations

calibrate-logo

Calibrate

Calibrate is a digital metabolic health business that is changing the way the world treats weight.

libre-foods-logo

Libre Foods

Libre Foods is a biotech startup on a mission to liberate the food system and create a more free future for people, the planet and animals.

lifelens-technologies-logo

LifeLens Technologies

LifeLens Technology is a biotechnology company that leads in innovative next generation treatment devices for personal health monitoring.

mindfule-logo

Mindfule

The Foodcare Company dedicated to improving brain and gut health through smart nutrition solutions.

testmate-health-logo

Testmate Health

Testmate Health builds self-testing kits that allow you you skip the waiting room & get results at home in minutes.

silvercloud-health-logo

SilverCloud Health

SilverCloud Health provides immediate access to evidence-based and supported digital therapies.

voyager-therapeutics-logo

Voyager Therapeutics

Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.


Current Advisors List

robert-mcquade_image

Robert McQuade Board Member @ COMPASS Pathways
Board_member
2020-04-01

Current Employees Featured

ekaterina-malievskaia_image

Ekaterina Malievskaia
Ekaterina Malievskaia Chief Innovation Officer & Co-Founder @ COMPASS Pathways
Chief Innovation Officer & Co-Founder

lars-christian-wilde_image

Lars Christian Wilde
Lars Christian Wilde President, Chief Business Officer & Co-Founder @ COMPASS Pathways
President, Chief Business Officer & Co-Founder
2017-03-01

george-goldsmith_image

George Goldsmith
George Goldsmith Executive Chairman, Chief Executive Officer & Co-Founder @ COMPASS Pathways
Executive Chairman, Chief Executive Officer & Co-Founder
2016-07-01

piers-morgan_image

Piers Morgan
Piers Morgan CFO @ COMPASS Pathways
CFO
2020-03-01

marco-mohwinckel_image

Marco Mohwinckel
Marco Mohwinckel Chief Commercial Officer @ COMPASS Pathways
Chief Commercial Officer
2018-05-01

kabir-nath_image

Kabir Nath
Kabir Nath Chief Executive @ COMPASS Pathways
Chief Executive
2022-07-01

steve-levine_image

Steve Levine
Steve Levine Vice President Patient Access @ COMPASS Pathways
Vice President Patient Access

susan-stansfield_image

Susan Stansfield
Susan Stansfield Senior Vice President, Clinical Operations @ COMPASS Pathways
Senior Vice President, Clinical Operations
2020-10-01

Founder


ekaterina-malievskaia_image

Ekaterina Malievskaia

george-goldsmith_image

George Goldsmith

lars-christian-wilde_image

Lars Christian Wilde

Stock Details


Company's stock symbol is FRA:5Y6

Investors List

perceptive-advisors_image

Perceptive Advisors

Perceptive Advisors investment in Series B - COMPASS Pathways

camden-partners_image

Camden Partners

Camden Partners investment in Series B - COMPASS Pathways

soleus-capital_image

Soleus Capital

Soleus Capital investment in Series B - COMPASS Pathways

mcquade-center-for-strategic-research-and-development_image

McQuade Center for Strategic Research and Development

McQuade Center for Strategic Research and Development investment in Series B - COMPASS Pathways

founders-fund_image

Founders Fund

Founders Fund investment in Series B - COMPASS Pathways

justin-mateen_image

Justin Mateen

Justin Mateen investment in Series B - COMPASS Pathways

atai-life-sciences-ag_image

ATAI Life Sciences

ATAI Life Sciences investment in Series B - COMPASS Pathways

able-partners_image

Able Partners

Able Partners investment in Series B - COMPASS Pathways

skyviews-life-science_image

Skyviews Life Science

Skyviews Life Science investment in Series B - COMPASS Pathways

wpss-bio_image

WPSS.bio

WPSS.bio investment in Convertible Note - COMPASS Pathways

Official Site Inspections

http://www.compasspathways.com Semrush global rank: 500.13 K Semrush visits lastest month: 99.51 K

  • Host name: 213.171.208.113
  • IP address: 213.171.208.113
  • Location: United Kingdom
  • Latitude: 51.4964
  • Longitude: -0.1224
  • Timezone: Europe/London

Loading ...

More informations about "COMPASS Pathways"

About Compass Pathways | Our Values & Mental Health Innovations

Jul 31, 2024 Compassion Everything we do is rooted in compassion. We care deeply about reducing people’s suffering, and we harness that passion to drive our work forward. Boldness …See details»

Compass Pathways - Investor Relations

We are Compass Pathways, a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is on improving the lives of those who …See details»

Compass Pathways - Wikipedia

Compass Pathways, or COMPASS Pathways, is a British pharmaceutical company developing psychedelics as potential medicines. Its main drug candidate, psilocybin (COMP360), is currently in phase 3 clinical trials for treatment-resistant depression. This candidate has received breakthrough therapy status from the U.S. Food and Drug Administration (FDA). It is the most advanced psychedelic drug candidate in development besides Lykos Therapeutics's midomafetamine (MD…See details»

Executive Team - Compass Pathways

News and views. News and views. Our collective understanding of mental illness is increasing all the time, with advances in neuroscience, psychotherapy, psychopharmacology and digital …See details»

Compass Pathways - Compass Pathways Announces Fourth …

Dec 31, 2024 LONDON & NEW YORK--(BUSINESS WIRE)-- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based …See details»

Compass Pathways - Compass Pathways Announces Third Quarter …

Oct 31, 2024 LONDON & NEW YORK--(BUSINESS WIRE)-- Compass Pathways plc (Nasdaq: CMPS) (“Compass”), a biotechnology company dedicated to accelerating access to evidence …See details»

COMPASS Pathways - Crunchbase Company Profile & Funding

Compass Pathways is a mental health care company that focuses on developing therapies for treatment-resistant depression. The company is involved in researching and developing …See details»

Compass Pathways Announces Fourth Quarter and Full-Year 2024 …

LONDON & NEW YORK, February 27, 2025--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based …See details»

COMPASS Pathways

2 days ago We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies.See details»

Partnerships - Compass Pathways

NAMI (National Alliance on Mental Illness) is the nation’s largest grassroots mental health organization dedicated to improving the lives of individuals affected by mental illness. They …See details»

COMPASS Pathways plc (CMPS)

COMPASS Pathways plc operates as a mental health care company in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that is in Phase III clinical trials …See details»

Compass Pathways - News & events - Events & presentations

Feb 27, 2025 ir@compasspathways.com. Follow us. follow us on LinkedIn; follow us on Youtube; follow us on X; Quick links. SEC Filings opens in new window. FAQs opens in new …See details»

Compass Pathways Announces Publication of Results from

5 days ago Forward-looking statements include express or implied statements relating to, among other things, statements regarding our business strategy and goals; our plans and …See details»

COMPASS Pathways

Contact: info@compasspathways.com Over 70% of patients in early studies rank psilocybin therapy among the top five most meaningful experiences of their lives. ... 1Statistics from …See details»

Compass Pathways Announces Publication of Results from …

5 days ago Media: Media, media@compasspathways.com Investors: Stephen Schultz, stephen.schultz@compasspathways.com , +1 401 290 7324 News Provided by Business Wire …See details»

Compass Pathways Announces Pricing of Underwritten Offering

LONDON & NEW YORK, January 10, 2025--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based …See details»

Mental Health Careers and Jobs | Compass Pathways

Jul 15, 2024 Join us. Join us. We are united by our commitment to improving mental health. Join us. Our culture; Diversity, equity and inclusion; Benefits; Careers; 60 seconds with ...See details»

Compasspathways.com - YourDigitalRights.org

Compasspathways.com. Delete your compasspathways.com account or request your data. ... Optionally provide any additional information which will help the organization to locate your …See details»

Compass Pathways - News & events - News

Ir@compasspathways.com. Follow us. follow us on LinkedIn; follow us on Youtube; follow us on X; Quick links. SEC Filings opens in new window. FAQs opens in new window. Investor email …See details»

Compass Pathways Announces Pricing of Underwritten Offering

Jan 10, 2025 Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced …See details»

linkstock.net © 2022. All rights reserved